Cash Equivalents - Aquestive Therapeutics Inc (NASDAQ:AQST) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 2.75 USD -2.14%

Updated:

Aquestive Therapeutics Inc
Cash Equivalents

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

Aquestive Therapeutics Inc
Cash Equivalents Peer Comparison

JNJ

BMY

PFE

MRK

LLY

Company		Cash Equivalents	CAGR 3Y	CAGR 5Y	CAGR 10Y
A	Aquestive Therapeutics Inc NASDAQ:AQST	Cash Equivalents $95.2m	CAGR 3-Years 51%	CAGR 5-Years 19%	CAGR 10-Years N/A
	Johnson & Johnson NYSE:JNJ	Cash Equivalents $3.8B	CAGR 3-Years 22%	CAGR 5-Years -2%	CAGR 10-Years -15%
	Bristol-Myers Squibb Co NYSE:BMY	Cash Equivalents $9.3B	CAGR 3-Years -5%	CAGR 5-Years 5%	CAGR 10-Years 6%
	Pfizer Inc NYSE:PFE	Cash Equivalents $719m	CAGR 3-Years -26%	CAGR 5-Years -18%	CAGR 10-Years -13%
	Merck & Co Inc NYSE:MRK	Cash Equivalents $5.6B	CAGR 3-Years -7%	CAGR 5-Years -7%	CAGR 10-Years -10%
	Eli Lilly and Co NYSE:LLY	Cash Equivalents $2.5B	CAGR 3-Years -6%	CAGR 5-Years 4%	CAGR 10-Years -4%

See Also

Based on the financial report for Mar 31, 2024, Aquestive Therapeutics Inc's Cash Equivalents amounts to 95.2m USD.

Over the last year, the Cash Equivalents growth was 254%. The average annual Cash Equivalents growth rates for Aquestive Therapeutics Inc have been 51% over the past three years , 19% over the past five years .

Join more than 146,000+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.